Phase 1 randomised controlled clinical trial testing the safety and efficacy of CPP-anti-VEGF for the treatment of neovascular age-related macular degeneration

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 76b14975ce7ca1e9bf298ef20f7141d978709667
First added on: Apr 08, 2025